Safeguard Investment Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Safeguard Investment Advisory Group's PFE Position: Q1 2026 in Review
Safeguard Investment Advisory Group reduced its Pfizer (PFE) stake by 7.2% in Q1 2026, selling an estimated $19K and leaving 9,281 shares worth $261K. The position accounts for 0.07% of the portfolio, ranked #111.
Safeguard Investment Advisory Group first reported a position in PFE in Q4 2020 and has held it in 16 quarters since. The position peaked at $484K in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Safeguard Investment Advisory Group held 9,281 shares of Pfizer worth $261K as of Q1 2026.
- Safeguard Investment Advisory Group sold 715 Pfizer shares in Q1 2026, an estimated $19K.
- Pfizer made up 0.07% of Safeguard Investment Advisory Group's portfolio in Q1 2026, its #111 holding.
- Safeguard Investment Advisory Group first reported a position in Pfizer in Q4 2020 and has held it in 16 quarters since.
- Safeguard Investment Advisory Group's Pfizer position peaked at $484K in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Safeguard Investment Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.